文献速递泌尿生殖技术与安全US

超声介导化疗药物递送进入转基因小鼠前列腺腺癌模型

Ultrasound-Mediated Delivery of Chemotherapy into the Transgenic Adenocarcinoma of the Mouse Prostate Model.
PubMed 文献 · Ultrasound Med Biol · 2020-08-13

本研究利用两种表型的自发性转基因小鼠前列腺腺癌(TRAMP)模型,评估超声联合微泡(US+MB)能否增强卡巴他赛(Cab)的疗效。卡巴他赛以游离药物静脉注射或纳米颗粒包裹形式给药,两种情况下均可短暂缩小肿瘤和前列腺体积;除一个肿瘤外,联合US+MB未观察到额外疗效,组织学分级和Ki67免疫染色在各治疗组间无差异。

要点

  • 在自发性TRAMP模型中,卡巴他赛无论游离或纳米包裹均仅短暂缩小肿瘤和前列腺体积。
  • 除一个肿瘤外,卡巴他赛联合超声+微泡未观察到额外治疗疗效。
  • 组织学分级与Ki67免疫染色在各治疗组间无差异。

核心结论

  • 在自发性、临床相关的小鼠前列腺癌模型中,卡巴他赛联合超声+微泡的治疗结果不同于异种移植模型中观察到的疗效增强。

研究设计与样本

  • 研究论文;采用两种表型的自发性转基因小鼠前列腺腺癌(TRAMP)模型;卡巴他赛以游离药物静脉注射或纳米颗粒包裹两种形式给药;评估超声联合微泡能否增强疗效;以组织学分级、Ki67免疫染色和质谱分析为评估手段。

关键影像表现/征象

  • 卡巴他赛在TRAMP模型中短暂缩小肿瘤和前列腺体积。
  • 除一个肿瘤外,卡巴他赛联合超声+微泡未观察到额外治疗疗效。
  • 组织学分级与Ki67免疫染色在各治疗组间无差异。

临床应用与阅片要点

  • 作者在自发性TRAMP模型中未观察到超声+微泡增强卡巴他赛疗效,该结果与异种移植模型中的疗效增强不同。
  • 质谱分析显示纳米颗粒包裹卡巴他赛较游离卡巴他赛延长循环时间并增强在肝脏和脾脏的蓄积。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Ultrasound (US) in combination with microbubbles (MB) has had promising results in improving delivery of chemotherapeutic agents. However, most studies are done in immunodeficient mice with xenografted tumors. We used two phenotypes of the spontaneous transgenic adenocarcinoma of the mouse prostate (TRAMP) model to evaluate if US + MB could enhance the therapeutic efficacy of cabazitaxel (Cab). Cab was either injected intravenously as free drug or encapsulated into nanoparticles. In both cases, Cab transiently reduced tumor and prostate volume in the TRAMP model. No additional therapeutic efficacy was observed combining Cab with US + MB, except for one tumor. Additionally, histology grading and immunostaining of Ki67 did not reveal differences between treatment groups. Mass spectrometry revealed that nanoparticle encapsulation of Cab increased the circulation time and enhanced the accumulation in liver and spleen compared with free Cab. The therapeutic results in this spontaneous, clinically relevant tumor model differ from the improved therapeutic response observed in xenografts combining US + MB and chemotherapy.

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. Fagerland ST, Berg S, Hill DK, et al. Ultrasound-Mediated Delivery of Chemotherapy into the Transgenic Adenocarcinoma of the Mouse Prostate Model. Ultrasound Med Biol. 2020. PMID: 32800470. doi:10.1016/j.ultrasmedbio.2020.07.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。